Exane Derivatives Lemonade, Inc. Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Lemonade, Inc. stock. As of the latest transaction made, Exane Derivatives holds 70 shares of LMND stock, worth $2,907. This represents 0.0% of its overall portfolio holdings.
Number of Shares
70
Previous 4,195
98.33%
Holding current value
$2,907
Previous $110,000
99.09%
% of portfolio
0.0%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding LMND
# of Institutions
268Shares Held
40.8MCall Options Held
2.62MPut Options Held
2.18M-
Softbank Group Corp Minato Ku Tokyo, M012MShares$498 Million0.94% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.21MShares$216 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4MShares$166 Million0.0% of portfolio
-
Baillie Gifford & CO3.73MShares$155 Million0.05% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.53MShares$63.5 Million0.02% of portfolio
About Lemonade, Inc.
- Ticker LMND
- Exchange NYSE
- Sector Financial Services
- Industry Insurance—Property & Casualty
- Shares Outstandng 68,945,600
- Market Cap $2.86B
- Description
- Lemonade, Inc. provides various insurance products in the United States and Europe. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property. The company also offers renters, homeowners, pet, car, and life in...